tm logo
CONEKSIS
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 26 Aug 2022

Last Applicant/ Owned by

3530 JOHN HOPKINS COURT

SAN DIEGO

CA

92121

Serial Number

85675473 filed on 12th Jul 2012

Registration Number

4927761 registered on 29th Mar 2016

in the Principal Register

Correspondent Address

Alicia M. Passerin

Leech Tishman Fuscaldo & Lampl

525 William Penn Place, 28th Floor

Pittsburgh PA 15219

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

CONEKSIS

cells for medical or clinical use; pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceutical for the treatment of cancer cells for scientific, laboratory or medical research

Classification Information


Class [001]
Chemical Products


cells for scientific, laboratory or medical research


First Use Date in General

26th Jan 2016

First Use Date in Commerce

26th Jan 2016

Class [005]
Pharmaceutical Products


cells for medical or clinical use; pharmaceutical products for the prevention and treatment of cancer; therapeutic pharmaceutical for the treatment of cancer


First Use Date in General

26th Jan 2016

First Use Date in Commerce

26th Jan 2016

Mark Details


Serial Number

No 85675473

Mark Type

No Service/Collective Mark

Attorney Docket Number

No NKW-1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
26th Aug 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
23rd Aug 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02th Mar 2022TEAS SECTION 8 & 15 RECEIVED
29th Mar 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
22nd Nov 2017AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
24th May 2017ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
27th Apr 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27th Apr 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29th Mar 2016REGISTERED-PRINCIPAL REGISTER
24th Feb 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED